Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas

Polish Journal of Pathology

Volumn 62, Issue 1, 2011, Pages 19-24

  Özgüven, Banu Yilmaz ^a   Karaçetin, Didem ^a   Kabukçuoglu, Fevziye ^a   Taskin, Tugba ^a   Yener, Şenay ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

catenin; Colorectal cancer; E cadherin; Immunohistochemistry; Prognostic factor

Indexed keywords

BETA CATENIN; CADHERIN; CTNNB1 PROTEIN, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; COLORECTAL TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MALE; METABOLISM; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CADHERINS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79957962462     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wong NA, Pignatelli M, et al. Beta-catenin - a linchpin in colorectal carcinogenesis? Am J Pathol 2002; 160: 389-401.
2. Hao X, Tomlinson I, Ilyas M, et al. Reciprocity between membranous and nuclear expression of beta catenin in colorectal tumours. Virchows Arch 1997; 431: 167-172.
3. Takeichi M. Cadherin cell adhesion receptors as a morpho-geneticregulator. Science 1991; 251: 1451-1455.
4. Overduin M, Harvey TS, Bagby S, et al. Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science 1995; 267: 386-389.
5. Nigam AK, Savage FJ, Boulos PB, et al. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer 1993; 68: 507-514.
6. Wheeler JM, Kim HC, Efstathiou JA, et al. Hypermethyla-tion of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 2001; 48: 367-371.
7. Tamura G, Yin J, Wang S, et al. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 2000; 92: 569-573.
8. Kim HC, Kim HJ, Kim JC, et al. Reduced E-cadherin expression as a cause of distinctive signet-ring cell variant in colorectal carcinoma. J Korean Med Sci 2002; 17: 23-28.
9. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cad-herin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993; 142: 987-993.
10. Mayer B, Johnson JP, Leitl F, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993; 53: 1690-1695.
11. Buda A, Pignatelli M, et al. Cytoskeletal network in colon cancer: from genes to clinical application. Int J Biochem Cell Biol 2004; 36: 759-765.
12. Xie D, Sham JS, Zeng WF, et al. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J Cancer 2003; 107: 896-902.
13. Tucker E, Buda A, Janghra B, et al. Abnormalities of the cad-herin-catenin complex in chemically-induced colo-rectal carcinogenesis. Proc Nutr Soc 2003; 62: 229-236.
14. Hayashida Y, Honda K, Idogawa M, et al. E-cadherin regulates the association between beta-catenin and actinin-4. Cancer Res 2005; 65: 8836-8845.
15. Kartenbeck J, Haselmann U, Gassler N, et al. Synthesis of junctional proteins in metastasizing colon cancer cells. Eur J Cell Biol 2005; 84: 417-430.
16. Tien YW, Jeng YM, Hu RH, et al. Intravasation-related metastatic factors in colorectal cancer. Tumour Biol 2004; 25: 48-55.
17. El-Bahrawy M, Poulsom R Rowan AJ, et al. Characterization of the E-cadherin/catenin complex in colorectal carcinoma cell lines. Int J Exp Pathol 2004; 85: 65-74.
18. Roca F, Mauro LV, Morandi A, et al. Prognostic value of E-cadherin, beta-catenin, metalloproteinases MMPs (7 and 9), and tissue inhibitors of metalloproteinases TIMPs (1 and 2) in patients with colorectal carcinoma. J Surg Oncol 2006; 93: 151-160.
19. Takayama T, Shiozaki H, Shibamoto S, et al. Beta-catenin expression in human cancers. Am J Pathol 1996; 148: 39-46.
20. Kudo Y, Kitajima S, Ogawa I, et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res 2004; 10: 5455-5463.
21. Takayama T, Shiozaki H, Doki Y, et al. Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer. Br J Cancer 1998; 77: 605-613.
22. Mohri Y. Prognostic significance of E-cadherin expression in human colorectal cancer tissue. Surg Today 1997; 27: 606-612.
23. Suzuki H, Masuda N, Shimura T, et al. Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma. Anticancer Res 2008; 28(3B): 1821-1830.
24. Lugli A, Zlobec I, Minoo P, et al. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis. Histopathology 2007; 50: 453-464.